Average cost of multi drug-resistant tuberculosis treatment in Tajikistan
Tajikistan: Average cost of multi drug-resistant tuberculosis treatment was 257 constant 2022 US$ in 2024. ▼ Falling
Latest (2024)
257 constant 2022 US$
Change on year
down 77.7%
World rank
90th
of 92 countries
All-time high
3,593 constant 2022 US$
in 2019
All-time low
257 constant 2022 US$
in 2024
Years of data
8
2017–2024
Average cost of multi drug-resistant tuberculosis treatment in Tajikistan, 2017–2024
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
Tajikistan recorded 257 constant 2022 US$ for average cost of multi drug-resistant tuberculosis treatment in 2024. That is the lowest value across all 8 years on record.
The figure is down 77.7% on the previous year and down 89.8% over ten years.
Tajikistan ranks 90th of 92 countries on this measure, in the bottom quarter.
Average cost of multi drug-resistant tuberculosis treatment in Tajikistan, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2017 | 2,525 constant 2022 US$ | — |
| 2018 | 2,060 constant 2022 US$ | -18.4% |
| 2019 | 3,593 constant 2022 US$ | +74.4% |
| 2020 | 3,321 constant 2022 US$ | -7.6% |
| 2021 | 1,690 constant 2022 US$ | -49.1% |
| 2022 | 2,663 constant 2022 US$ | +57.6% |
| 2023 | 1,155 constant 2022 US$ | -56.6% |
| 2024 | 257 constant 2022 US$ | -77.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 2,726 constant 2022 US$ | 2,060 constant 2022 US$ | 3,593 constant 2022 US$ | 3 |
| 2020s | 1,817 constant 2022 US$ | 257 constant 2022 US$ | 3,321 constant 2022 US$ | 5 |
Countries ranked near Tajikistan
- 87 India 400 constant 2022 US$ compare
- 88 Sierra Leone 369 constant 2022 US$ compare
- 89 Philippines 310 constant 2022 US$ compare
- 91 Burkina Faso 159 constant 2022 US$ compare
- 92 Lesotho 81 constant 2022 US$ compare
More health data for Tajikistan
- Un projection of annual infant deaths, annual growth rate -1.94 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.9561 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 887 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,061 deaths (2100)
- Population ages 50-54, male, annual growth rate 1.33 % change on previous year (2025)
- Population ages 50-54, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 50-54, male, per capita 0.018 units per person (2025)
- Population ages 55-59, female, annual growth rate 1.6 % change on previous year (2025)
- Population ages 55-59, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 55-59, female, per capita 0.0176 units per person (2025)
Frequently asked questions
- What is average cost of multi drug-resistant tuberculosis treatment in Tajikistan?
- Average cost of multi drug-resistant tuberculosis treatment in Tajikistan was 257 constant 2022 US$ in 2024, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of multi drug-resistant tuberculosis treatment recorded in Tajikistan?
- The highest recorded value was 3,593 constant 2022 US$ in 2019.
- What is the lowest average cost of multi drug-resistant tuberculosis treatment recorded in Tajikistan?
- The lowest recorded value was 257 constant 2022 US$ in 2024.
- How does Tajikistan rank for average cost of multi drug-resistant tuberculosis treatment?
- Tajikistan ranks 90th out of 92 countries with data for 2024.
- Is average cost of multi drug-resistant tuberculosis treatment rising or falling in Tajikistan?
- Over the last ten years it is down 89.8%. The long-run trend across the full record is falling.
- Where does this Tajikistan data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of multi drug-resistant tuberculosis treatment. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 8 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.